Common Contracts
1 similar The Clinical Trial Agreement contracts
AMENDMENT # 1 TO THE CLINICAL TRIAL AGREEMENTThe Clinical Trial Agreement • April 21st, 2021
This Amendment 1 (the “Amendment”) dated 16Feb2021 to the Clinical Trial Agreement, fully executed on 05Feb2019 (the “ Agreement”) for the clinical study conducted in accordance with the Protocol ID-054-304 (REACT) titled: “ A prospective, multi- center, double-blind, randomized, placebo-controlled, parallel-group, Phase 3 study to assess the efficacy and safety of clazosentan in preventing clinical deterioration due to delayed cerebral ischemia (DCI), in adult subjects with aneurysmal subarachnoid hemorrhage (aSAH) ” and any amendments thereto (the “Study”), has been concluded by and between:
